LifeStance Health Group, Inc. Common Stock
Here’s whether LifeStance Health Group, Inc. Common Stock (LFST) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+8.03% over 10 days); RSI 49 — healthy momentum range; strong 1-year return of +163.3%; 3-month momentum positive (+54.6%). Concerns: declining volume on rally — weak conviction (0.77x 30d avg). Currently 7.3% off its 52-week high. Score: +6/7.
LFST is in a confirmed uptrend, trading above both its 50-day ($9.25) and 200-day ($7.28) moving averages. An RSI of 48.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +163.3% compares to +16.5% for SPY (beat the market by 146.8%).